enkephalin, leucine has been researched along with Neoplasms, Skull in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asa, SL; BĂ©lair, M; Berthelet, F; Serri, O; Vallette, S | 1 |
Gershow, J; Krames, ES; Wilkie, DJ | 1 |
2 other study(ies) available for enkephalin, leucine and Neoplasms, Skull
Article | Year |
---|---|
An unusual association of a sellar gangliocytoma with a prolactinoma.
Topics: Chemotherapy, Adjuvant; Dopamine Agonists; Enkephalins; Female; Ganglioneuroma; Hormone Replacement Therapy; Humans; Hypothalamic Neoplasms; Magnetic Resonance Imaging; Neoplasms, Multiple Primary; Neurosurgical Procedures; Pituitary Neoplasms; Prolactin; Prolactinoma; Sella Turcica; Skull Neoplasms; Treatment Outcome; Young Adult | 2008 |
Intrathecal D-Ala2-D-Leu5-enkephalin (DADL) restores analgesia in a patient analgetically tolerant to intrathecal morphine sulfate.
Topics: Aged; Carcinoma; Clonidine; Drug Tolerance; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Humans; Injections, Spinal; Male; Morphine; Naloxone; Pain, Intractable; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, mu; Skull Neoplasms; Spinal Neoplasms; Substance Withdrawal Syndrome; Thyroid Neoplasms | 1986 |